Cargando…
SARS-CoV-2 IgG Antibody and its Clinical Correlates in Convalescent Plasma Donors: An Indian Experience
SARS-CoV-2, a novel coronavirus, emerged a year ago in Wuhan, China causing a new pandemic. Convalescent plasma therapy has been applied previously to many infectious diseases and has shown a successful result. This study was planned to assess the Anti-SARS-CoV-2 IgG antibody levels in convalescent...
Autores principales: | Kumar, PVSN Kiran, Banerjee, Mithu, Bajpayee, Archana, Mandal, Saptarishi, Mitra, Prasenjit, Sharma, Praveen, Misra, Sanjeev, Bhardwaj, Pankaj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599420/ https://www.ncbi.nlm.nih.gov/pubmed/34812224 http://dx.doi.org/10.1007/s12291-021-01012-w |
Ejemplares similares
-
Impact of COVID-19 on Clinical Biochemistry: Indian Scenario
por: Mitra, Prasenjit, et al.
Publicado: (2021) -
Interleukin-6 Perpetrator of the COVID-19 Cytokine Storm
por: Shekhawat, Jyoti, et al.
Publicado: (2021) -
Associations Between Symptoms, Donor Characteristics and IgG Antibody Response in 2082 COVID-19 Convalescent Plasma Donors
por: Vinkenoog, Marieke, et al.
Publicado: (2022) -
Snapshot of COVID-19 Related Clinical Trials in India
por: Charan, Jaykaran, et al.
Publicado: (2020) -
Analysis of the IgG subclass profile and IgG sum-total discrepancy in COVID-19 convalescent plasma donors: A single-centre prospective cohort study
por: Wasiluk, Tomasz, et al.
Publicado: (2023)